The Fine Needle Aspiration (FNA) biopsy is a diagnostic procedure used to investigate lumps or masses. With this technique, a thin, hollow needle is inserted into the mass for sampling of cells that, once stained, are examined under a microscope.
As indicated by numbers of international studies, the ROSE method, rapid on-site evaluation, has the potential to improve the adequacy rates of fine-needle aspiration (FNA) cytology.
With the term Rapid On-Site Evaluation (ROSE) we refer to a service that the cytopathology laboratory provides for patients and their physicians.
The advantages include assurance of FNA biopsy adequacy, the ability to triage the specimen, shorten the length of the procedure, direct the biopsy in real-time and assist in managing the patient’s procedure with the performing clinician at the point of care.
ROSE service for FNA biopsy is a time-limited procedure which occurs while patients are subject to varying degrees of sedation and while they have endoscopes or large needles placed within the cavity or abdomen. As such, it is important to collect and deliver images of the highest quality as quickly as possible.
Milestone’s mission to help patients is achieved by continuously developing new ideas that bring innovative products to the market, with the final goal of improving the diagnostic process.
In cooperation with Professor Mousa Al Abbadi, Milestone has created a new innovative product, the RoseSTATION, an all-in-one mobile workstation for Rapid On-Site Evaluation (ROSE) of FNA cytology.